ClinicalTrials.Veeva

Menu

Hypercoagulability After Breast Cancer Surgery (EHC)

I

Institut Bergonié

Status

Completed

Conditions

Breast Cancer
Blood Coagulation Disorders

Treatments

Procedure: Blood collection (pre and postoperative): plasma coagulation parameters

Study type

Observational

Funder types

Other

Identifiers

NCT00210197
IB2005-06
EHC

Details and patient eligibility

About

The risk of deep venous thrombosis after radical breast surgery is known. The objective of this study is to explore hypercoagulability after radical breast cancer surgery by studying several factors for haemostasis before, during and after surgery. Ultrasound Doppler examination is realised between 24 and 72 hours post-operatively. Hypercoagulability is defined by a significant increasing level of thrombin-antithrombin, D-dimer and the endogen thrombin potential.

Enrollment

48 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Breast cancer
  • mastectomy

Exclusion criteria

  • thrombophilia
  • anticoagulant treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems